Benitec Biopharma (BNTC) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 13, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about BNTC filings

Are insiders buying or selling Benitec Biopharma Inc. (BNTC) stock?

Neither. Benitec Biopharma Inc. (BNTC) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNTC recently?

None. No member of Congress disclosed a BNTC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNTC smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

13 funds hold a position.

Questions about BNTC filings

Are insiders buying or selling Benitec Biopharma Inc. (BNTC) stock?

Neither. Benitec Biopharma Inc. (BNTC) insiders filed no open-market purchases or sales in the 90 days to Nov 13, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNTC recently?

None. No member of Congress disclosed a BNTC trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNTC smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 13, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 13, 2026

Period ending

Sep 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$0.00

Yahoo Finance

Revenue: Yahoo Finance

Next report

Estimated report: Nov 13, 2026, today

Estimates as of Nov 13, 2026

EPS expected

-$0.29

-$0.34 to -$0.26

Last 30 days

1up2down

Analysts cutting estimates

Estimate drift

0.01

Change in 30 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 13, 2026	Not on file	No estimate	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2026Reported Sep 14, 2026	-$0.26est. -$0.26	+0.00%in line	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 14, 2026	-$0.24est. -$0.28	+14.29%beat	$0.00SEC filing	No year-ago quarter
Dec 31, 2025Reported Feb 12, 2026	-$0.26est. -$0.23	-13.04%miss	$0.00SEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 14, 2025	-$0.22est. -$76.32	+99.71%beat	$0.00SEC filing	No year-ago quarter
Jun 30, 2025Reported Sep 22, 2025	-$0.42est. -$0.31	-35.48%miss	Not on file	Not on file
Mar 31, 2025Reported May 14, 2025	-$0.24est. -$0.35	+31.43%beat	$0.00SEC filing	No year-ago quarter
Dec 31, 2024Reported Feb 14, 2025	-$0.33est. -$0.78	+57.69%beat	$0.00SEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $9.39
High: $9.39
Low: $8.80
Prev close: $9.47
52-wk high: $14.39
52-wk low: $7.88
Mkt cap: $330.4M
ROE: -33.2%
Beta: 0.24
P/S: 2770.1x
P/B: 1.8x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $330M

Valuation

P/S2770.13
P/B1.83

Quality

Operating margin0.0%
ROE-33.2%
ROA-22.7%

Growth

Beta0.24

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

55balanced

20D volatility

79%annualized

52-week range

$9.09

$7.88$14.39

20D support

$7.88recent floor

20D resistance

$10.23recent ceiling

Returns

5D +5.2%20D +7.4%60D -32.1%

Price vs moving averages

SMA20 +2.6%SMA50 -6.7%SMA200 -20.3%

Volume pace

0.94xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 13, 2026

Not on file

No estimate

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2026Sep 14, 2026

-$0.26est. -$0.26

+0.00%

$0.00Yahoo Finance

No year-ago quarter

Mar 31, 2026May 14, 2026

-$0.24est. -$0.28

+14.29%

$0.00SEC filing

No year-ago quarter

Dec 31, 2025Feb 12, 2026

-$0.26est. -$0.23

-13.04%

$0.00SEC filing

No year-ago quarter

Sep 30, 2025Nov 14, 2025

-$0.22est. -$76.32

+99.71%

$0.00SEC filing

No year-ago quarter

Jun 30, 2025Sep 22, 2025

-$0.42est. -$0.31

-35.48%

Not on file

Mar 31, 2025May 14, 2025

-$0.24est. -$0.35

+31.43%

$0.00SEC filing

No year-ago quarter

Dec 31, 2024Feb 14, 2025

-$0.33est. -$0.78

+57.69%

$0.00SEC filing

No year-ago quarter

Benitec Biopharma Inc.

Smart money at a glance

What do analysts expect?

Questions about BNTC filings

Questions about BNTC filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Nov 13, 2026, today

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Benitec Biopharma Inc.

Smart money at a glance

What do analysts expect?

Questions about BNTC filings

Questions about BNTC filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

Estimated report: Nov 13, 2026, today

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Benitec Biopharma Inc.

Overview

Questions about BNTC filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Benitec Biopharma Inc.

Overview

Questions about BNTC filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.